| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 8 | |
| #2 | Australia | 4 | |
| #3 | Canada | 3 | |
| #4 | China | 3 | |
| #5 | EPO (European Patent Office) | 3 | |
| #6 | WIPO (World Intellectual Property Organization) | 2 | |
| #7 | Brazil | 1 | |
| #8 | Hong Kong | 1 | |
| #9 | Israel | 1 | |
| #10 | Mexico | 1 | |
| #11 | Malaysia | 1 | |
| #12 | Singapore | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Environmental technology | |
| #4 | Computer technology | |
| #5 | Machines |
| # | Name | Total Patents |
|---|---|---|
| #1 | Bodie Neil M | 27 |
| #2 | Altman Elliot | 17 |
| #3 | Bodie Renee | 6 |
| #4 | Neil M Bodie | 1 |
| Publication | Filing date | Title |
|---|---|---|
| AU2011253771A1 | Method for inhibiting immune complex formation in a subject | |
| SG10201500597YA | Methods for treating immune-mediated dengue fever infections and antibody-dependent enhancement of dengue fever infections, including dengue hemorrhagic fever and dengue shock syndrome | |
| EP1940436A1 | Methods for treating immune mediated neurological diseases | |
| AU2005221187A1 | Method for inhibiting immune complex formation in a subjetc | |
| US2005148030A1 | Inhibition of immune complex formation |